Attention-Deficit Hyperactivity Disorder

Seminars in Pediatric Neurology

Volumn 13, Issue 4, 2006, Pages 279-285

  Wolraich, Mark L ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

attention deficit hyperactivity disorder; behavior modification; stimulant medications

Indexed keywords

ADDERALL XL; AMPHETAMINE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; DEXOSTAT; FOCALIN XR; METHYLIN ER; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PHENYLBUTAZONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; APPETITE; ATTENTION DEFICIT DISORDER; BEHAVIOR; BEHAVIOR MODIFICATION; BLOOD PRESSURE; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DRUG DOSAGE FORM; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSKINESIA; DYSPEPSIA; FAMILY COUNSELING; GASTROINTESTINAL SYMPTOM; GILLES DE LA TOURETTE SYNDROME; GLAUCOMA; GROWTH INHIBITION; HALLUCINATION; HEART RATE; HUMAN; IRRITABILITY; LIVER TOXICITY; MANIA; MOOD; MUSCLE INJURY; NAUSEA; NERVOUSNESS; OPTIMAL DRUG DOSE; PARENT; PATIENT INFORMATION; RECOMMENDED DRUG DOSE; REVIEW; SCHOOL HEALTH SERVICE; SIDE EFFECT; SKIN BRUISING; SLEEP; SOMNOLENCE; STATISTICAL ANALYSIS; STUTTERING; SUICIDAL IDEATION; TIC; TREATMENT RESPONSE; WEIGHT REDUCTION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; HUMANS; PEDIATRICS;

EID: 33845457706     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2006.09.008     Document Type: Review

References (20)

1. Perrin J.M., Stein M.T., Amler R.W., et al. Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105 (2000) 1158-1170
2. Perrin J.M., Stein M.T., Amler R.W., et al. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108 (2001) 1033-1044
3. National Institutes of Health Consensus Development Conference Statement. Diagnosis and treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 39 (1999) 182-188
4. Swanson J., and Castellanos F. Biological bases of ADHD-Neuroanatomy, genetics and pathophysiology. In: Jensen P., and Cooper J. (Eds). Attention Deficit Hyperactivity Disorder: State of the Science-Best Practices (2002), Civic Research Institute, Kingston, NJ
5. Baumgaertel A., and Wolraich M.L. Practice guideline for the diagnosis and management of attention deficit hyperactivity disorder. Ambulatory Child Health 4 (1998) 45-58
6. Brown R.T., Freeman W.S., Perrin J.M., et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 107 (2001) e43
7. Simpson D., and Perry C.M. Atomoxetine. Pediatric Drugs 5 (2003) 407-415
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (ed 4). Text Revision (2000), American Psychiatric Association, Washington, DC
9. Wolraich M.L., Lambert W., Worley K., et al. Psychometric properties of the Vanderbilt ADHD Diagnostic Parent Rating Scale. J Pediatr Psychol 28 (2003) 559-568
10. Achenbach T.M., and Rescorla L.A. Manual for the ASEBA School-Age Forms & Profiles. Research Center for Children, Youth, & Families (2001), University of Vermont, Burlington, VT
11. Wolraich M.L., Feurer I., Hannah J.N., et al. Obtaining systematic teacher report of disruptive behavior disorders utilizing DSM-IV. J Abnorm Child Psychol 26 (1998) 141-152
12. Touwen B., and Kalverboer A.F. Neurologic and behavioral assessment of children with minimal brain dysfunction. Semin Psychiatry 5 (1973) 79-94
13. Maloney M., and Glasser A. An evaluation of the clinical utility of the Draw-a-Person Test. J Clin Psychol 38 (1982) 183-190
14. Bodenheimer T., Wagner E.H., and Grumbach K. Improving primary care for patients with chronic illness. JAMA 288 (2002) 1775-1779
15. Bodenheimer T., Wagner E.H., and Grumbach K. Improving primary care for patients with chronic illness: The chronic care model, part 2. JAMA 288 (2002) 1909-1914
16. Greenhill L.L., Halperin J.M., and Abikoff H. Stimulant Medications. J Am Acad Adolesc Psychiatry 38 (1999) 503-512
17. Pelham W., Wheeler T., and Chronis A. Empirically supported psychological treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 27 (1998) 190-205
18. Greenhill L.L. Attention-deficit hyperactivity disorder: The stimulants. Child Adolesc Psychiatr Clin N Am 4 (1995) 123-168
19. Jensen P.S., Hinshaw S.P., Swanson J.M., et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. J Dev Behav Pediatr 22 (2001) 60-73
20. Allen A., Kurlan R.M., Gilbert D.L., et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 65 (2005) 1941-1949